EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180 | -1.1% | 23,120 | +4.8% | 0.00% | 0.0% |
| Q2 2023 | $182 | +18.2% | 22,064 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $154 | -17.2% | 21,183 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $186 | -99.9% | 20,961 | -6.6% | 0.00% | -50.0% |
| Q3 2022 | $275,000 | +111.5% | 22,450 | +104.4% | 0.00% | +100.0% |
| Q2 2022 | $130,000 | -51.3% | 10,983 | -21.8% | 0.00% | 0.0% |
| Q1 2022 | $267,000 | -24.1% | 14,040 | +5.8% | 0.00% | -50.0% |
| Q4 2021 | $352,000 | -19.8% | 13,269 | +24.0% | 0.00% | 0.0% |
| Q3 2021 | $439,000 | -3.9% | 10,697 | +32.7% | 0.00% | -33.3% |
| Q2 2021 | $457,000 | +59.2% | 8,063 | +17.8% | 0.00% | +50.0% |
| Q1 2021 | $287,000 | -25.8% | 6,843 | +24.1% | 0.00% | 0.0% |
| Q4 2020 | $387,000 | +56.7% | 5,514 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $247,000 | -2.4% | 6,902 | -16.2% | 0.00% | 0.0% |
| Q4 2017 | $253,000 | +954.2% | 8,240 | +725.7% | 0.00% | – |
| Q2 2016 | $24,000 | – | 998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |